Status:
UNKNOWN
JASPER Early Intervention for Tuberous Sclerosis
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Boston Children's Hospital
Conditions:
Tuberous Sclerosis
Eligibility:
All Genders
6-40 years
Phase:
NA
Brief Summary
The investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention administered remotely that ...
Detailed Description
Tuberous Sclerosis Complex (TSC) is a genetic disorder caused by mutations in either the TSC1 or TSC2 genes. The genetic variation results in the growth of non-malignant tumors throughout the body. Ne...
Eligibility Criteria
Inclusion
- A confirmed diagnosis of Tuberous Sclerosis Complex
Exclusion
- A mental age less than 6 months. A plan for epilepsy surgery during the study participation period.
Key Trial Info
Start Date :
October 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03422367
Start Date
October 24 2017
End Date
June 15 2022
Last Update
November 6 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Los Angeles
Los Angeles, California, United States, 90065
2
Boston Children's Hospital
Boston, Massachusetts, United States, 02215